Cidara Therapeutics Inc. (CDTX)
NASDAQ: CDTX
· Real-Time Price · USD
65.38
1.83 (2.88%)
At close: Aug 15, 2025, 3:59 PM
66.25
1.33%
After-hours: Aug 15, 2025, 06:59 PM EDT
Cidara Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | 302K | 8.46M | 17.58M | 12.72M | 7.61M | 26.11M | 10.22M | 40.74M | 6.22M | 7.11M | 7.22M | 7.08M | 32.86M | 2.41M |
Cost of Revenue | 27K | 49K | 83.26M | 61K | 57K | 1.56M | 1.14M | 387K | 401K | n/a | 29K | 37K | 38K | 39K | 37K | 20.5M | 17.72M | 15.85M |
Gross Profit | -27K | -49K | -90.75M | -61K | 245K | 6.9M | 16.45M | 12.33M | 7.21M | 26.11M | 10.19M | 40.71M | 6.18M | 7.07M | 7.19M | -13.43M | 15.14M | -13.44M |
Operating Income | -31.32M | -25.27M | -54.18M | -17.39M | -11.1M | -10.69M | -6.07M | -4.47M | -12.83M | 2.78M | -13.27M | 14.92M | -13.11M | -18.26M | -16.77M | -18.04M | 10.77M | -18.22M |
Interest Income | 1.67M | 1.9M | 1.81M | 1.86M | 1.77M | 365K | 527K | 613K | 623K | 232K | 162K | 55K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -25.72M | -23.48M | -52.37M | -15.54M | -94.21M | -10.33M | -5.55M | -3.85M | -12.21M | 3.01M | -13.11M | 14.98M | -13.12M | -18.28M | -16.8M | -18.08M | 10.71M | -18.29M |
Net Income | n/a | -23.48M | -52.31M | -15.54M | -89.41M | -10.33M | -5.61M | -8.17M | -12.36M | 3.01M | -13.38M | 11.9M | -13.13M | -18.3M | -16.8M | -18.08M | 8.82M | -18.29M |
Selling & General & Admin | 6.5M | 6.18M | 7.31M | 4.96M | 4.69M | 6M | 7.17M | 3.56M | 3.31M | 4.46M | 3.43M | 5.78M | 4.07M | 5.2M | 4.98M | 4.61M | 4.37M | 4.78M |
Research & Development | 24.82M | 24.6M | 46.87M | 12.43M | 6.66M | 11.59M | 15.35M | 17.33M | 17.14M | 18.87M | 20.06M | 20.04M | 15.26M | 20.17M | 19.01M | 20.5M | 17.72M | 15.85M |
Other Expenses | n/a | -5.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 31.32M | 25.27M | 54.18M | 17.39M | 11.35M | 17.59M | 22.52M | 20.89M | 20.45M | 23.33M | 23.49M | 25.82M | 19.33M | 25.37M | 24M | 25.11M | 22.09M | 20.63M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 623K | n/a | n/a | n/a | 6K | 20K | 33K | 47K | 62K | 70K |
Selling & Marketing Expenses | n/a | n/a | -13.31M | n/a | -57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 31.32M | 25.27M | 54.18M | 17.39M | 96.29M | 19.15M | 23.66M | 21.27M | 20.45M | 23.33M | 23.49M | 25.82M | 19.33M | 25.37M | 24M | 25.11M | 22.09M | 20.63M |
Income Tax Expense | n/a | n/a | n/a | n/a | -4.8M | -56K | 64K | -32K | 149K | n/a | 272K | -110K | 6K | 20K | 33K | 72K | -16K | -17K |
Shares Outstanding (Basic) | 15.55M | 14.18M | 9.73M | 6.53M | 4.56M | 4.54M | 4.49M | 4.51M | 4.41M | 3.93M | 3.59M | 3.52M | 2.63M | 3.39M | 3.22M | 2.44M | 2.44M | 2.1M |
Shares Outstanding (Diluted) | 15.55M | 14.18M | 9.73M | 6.53M | 4.56M | 4.54M | 4.53M | 4.51M | 4.51M | 5.06M | 3.59M | 4.43M | 3.46M | 3.41M | 3.22M | 2.48M | 2.97M | 2.35M |
EPS (Basic) | -1.65 | -1.66 | -5.37 | -2.38 | -19.59 | -2.28 | -1.25 | -1.81 | -2.8 | 0.77 | -3.72 | 3.39 | -4.98 | -5.41 | -5.22 | -7.4 | 3.62 | -8.72 |
EPS (Diluted) | -1.65 | -1.66 | -5.37 | -2.38 | -19.59 | -2.28 | -1.24 | -1.81 | -2.74 | 0.60 | -3.72 | 3.38 | -3.8 | -5.37 | -5.21 | -7.3 | 3.61 | -7.79 |
EBITDA | -27.38M | -25.22M | -54.12M | -17.33M | -11.06M | -10.27M | -6.04M | -3.83M | -6.72M | 2.81M | -13.08M | 14.96M | -13.07M | -18.22M | -16.73M | -17.99M | 10.82M | -18.16M |
EBIT | -25.72M | -25.27M | -54.18M | -17.39M | -11.1M | -10.33M | -6.07M | -3.85M | -6.75M | 2.78M | -13.11M | 14.92M | -13.11M | -18.26M | -16.77M | -18.04M | 10.77M | -18.22M |
Depreciation & Amortization | 27K | 49K | 59K | 61K | 57K | 56K | 39K | 22K | 401K | 32K | 29K | 37K | 38K | 39K | 37K | 45K | 50K | 57K |